896101-79-4

Basic information

• Product Name: TERT-BUTYL 3-(CYANOMETHYL)-5-METHOXY-1H-INDOLE-1-CARBOXYLATE
• Synonyms: TERT-BUTYL 3-(CYANOMETHYL)-5-METHOXY-1H-INDOLE-1-CARBOXYLATE
• CAS NO: 896101-79-4
• Molecular Formula: C16H18N2O3
• Molecular Weight: 286.32572
• Mol File: 896101-79-4.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: TERT-BUTYL 3-(CYANOMETHYL)-5-METHOXY-1H-INDOLE-1-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 3-(CYANOMETHYL)-5-METHOXY-1H-INDOLE-1-CARBOXYLATE(896101-79-4)
• EPA Substance Registry System: TERT-BUTYL 3-(CYANOMETHYL)-5-METHOXY-1H-INDOLE-1-CARBOXYLATE(896101-79-4)

Safety Data

• Hazardous Substances Data: 896101-79-4(Hazardous Substances Data)

Usage

General Description

TERT-BUTYL 3-(CYANOMETHYL)-5-METHOXY-1H-INDOLE-1-CARBOXYLATE is a chemical compound with a complex molecular structure. It is a derivative of 5-methoxy-1H-indole-3-carboxylic acid, with a tert-butyl group attached to the nitrogen atom and a cyanomethyl group attached to the third carbon atom. TERT-BUTYL 3-(CYANOMETHYL)-5-METHOXY-1H-INDOLE-1-CARBOXYLATE is commonly used in the pharmaceutical industry for the synthesis of various drugs and biologically active molecules. It exhibits potential pharmacological properties, making it an important building block in drug discovery and development. As with any chemical compound, it should be handled and used with caution, following the necessary safety protocols.

Upstream product

• 2436-17-1 5-methoxyindole-3-acetonitrile 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1006-94-6 5-methoxylindole 
• 190182-60-6 diethyl-(5-methoxy-1H-indol-3-ylmethyl)-amine 
• 10601-19-1 5-methoxyindole-3-carboxaldehyde 

Downstream Products

• 907602-77-1 tert-butyl-3-(2-cyanopropan-2-yl)-5-methoxy-1H-indole-1-carboxylate 
• 20731-70-8 5-methoxy-α-methyltryptamine 

Relevant articles and documents

Substituted heteroaryl compounds and compositions and uses thereof

The present invention relates to a novel heteroaromatic compound, and a pharmaceutical composition containing the compound. The heteroaromatic compound or pharmaceutical composition containing the compound can be used for exciting a melatonin receptor. The present invention also relates to a preparation method of the compound and pharmaceutical composition thereof, and application of the compound and pharmaceutical composition in treating central nervous system dysfunction of mammals especially human.

Use of derivatives of indoles for the treatment of cancer

The present invention relates to the use of derivatives of indoles having a general formula (I) as follow: for the manufacture of a pharmaceutical composition intended for the treatment of cancer.

The discovery of carboline analogs as potent MAPKAP-K2 inhibitors

The discovery of a series of potent, carboline-based MK2 inhibitors is described. These compounds inhibit MK2 with IC50s as low as 10 nM, as measured in a DELFIA assay. An X-ray crystal structure reveals that they bind in a region near the p-lo